Approval · Notice of Compliance 2875 · 1998
ERWINASE: Notice of Compliance 2875
Issued April 15, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2875
- Date
- April 15, 1998
- Company
- Ipsen Limited
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Cytostatic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ERWINASE | 02237815 | Cancelled Post Market |
Medicinal ingredients
- ERWINIA L-ASPARAGINASE 10,000 UNIT per VIAL